RxDoctor Payments Data

Akshay Garg, MD

Pain Medicine · Rockville, MDNPI 1518223411

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 46.3% of the total. Reporting peaked in 2019 at $8,587 and has fallen 89.5% since, to $906 in 2025.

$17,702in general payments, 2019–2025

Across 179 payments — averaging $98.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biodelivery Sciences International, Inc.$8K
  • Abbott$5K
  • Medtronic$2K
  • Boston Scientific$975
  • Painteq LLC$221
  • Nevro Corp.$187
  • plus $863 from 15 others

What the payments were for

  • Speaking & faculty fees$6,88039%
  • Travel & lodging$2,71115%
  • Food & beverage$7,91645%
  • Education$760%
  • Entertainment$1181%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,702 in reported general payments places this provider in the 85th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$297,785
Medicare patients
482
Services billed
4,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin110$690
Pregabalin21$507

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →